Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma

PLoS ONE(2021)10.1371/journal.pone.0247640Source: DataRank Database

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 73 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access73 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 4.03)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Salum J. Lidenge ORCID,Lisa K. Poppe ORCID,Phoebe B. Peña,Sara R. Privatt,Sydney J. Bennett

Live enrichment

PubMed:33661923 PMC:PMC7932539 OpenAlex:https://openalex.org/W3133805672

National Cancer Institute

Grant: U54 CA190155

Fogarty International Center

Grant: K43TW011418

Fogarty International Center

Grant: D43 TW010354

National Institute of Allergy and Infectious Diseases

Grant: T32 AI125207

National Institute of General Medical Sciences

Grant: P20 GM103427

NIGMS NIH HHS

Grant: U54 GM104940

FWCI

4.03

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247640&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247640&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0247640

journalhttps://doi.org/10.1371/journal.pone.0247640

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33661923

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approachesAdultAgedAged, 80 and overAntibodies, NeutralizingAntibodies, ViralAntibody-Dependent Cell CytotoxicityCOVID-19FemaleHEK293 CellsHumansImmunoglobulin GMaleMiddle AgedSARS-CoV-2Spike Glycoprotein, CoronavirusYoung Adult

MeSH Terms

COVID-19SARS-CoV-2AdultAgedAged, 80 and overAntibodies, ViralAntibody-Dependent Cell CytotoxicityFemaleHumansImmunoglobulin GMaleMiddle AgedYoung AdultAntibodies, NeutralizingHEK293 CellsSpike Glycoprotein, Coronavirus

Keywords

Antibody-dependent cell-mediated cytotoxicityAntibodyVirologyNeutralizing antibodyNeutralizationCoronavirus disease 2019 (COVID-19)Immune systemImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyMedicineMonoclonal antibodyInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being